Takeda mentors share their
EVENTS AND PROGRAMS
There are no events or programs to display at this time.
There are no events or programs to display at this time.
Connect with a dedicated OnePath Patient Support Manager now.
VPRIV® (velaglucerase alfa) for injection is a prescription medication indicated for long-term enzyme replacement therapy (ERT) for patients with type 1 Gaucher disease.
VPRIV® (velaglucerase alfa) for injection is a prescription medication indicated for long-term enzyme replacement therapy (ERT) for patients with type 1 Gaucher disease.
VPRIV® (velaglucerase alfa) for injection is a prescription medication indicated for long-term enzyme replacement therapy (ERT) for patients with type 1 Gaucher disease.
You are being directed to another site.
Please be advised that Takeda may not have control over the content or presentation of the site you are about to view.
You are being directed to another site.
The information contained in this section of the site is intended for US health care professionals only. Click Continue if you are a health care professional.